US 12,076,310 B2
Compounds and methods for the treatment of acute myelogenous leukemia
Deepak Sahasrabudhe, Rochester, NY (US); and Rakesh K. Singh, Rochester, NY (US)
Assigned to University of Rochester, Rochester, NY (US)
Filed by University of Rochester, Rochester, NY (US)
Filed on Jun. 8, 2022, as Appl. No. 17/835,545.
Claims priority of provisional application 63/208,540, filed on Jun. 9, 2021.
Prior Publication US 2023/0000823 A1, Jan. 5, 2023
Int. Cl. A61K 31/404 (2006.01); A61P 35/02 (2006.01)
CPC A61K 31/404 (2013.01) [A61P 35/02 (2018.01)] 3 Claims
 
1. A method of treating acute myeloid leukemia in a subject having acute myeloid leukemia, wherein the method comprises administering to the subject a compound selected from the group consisting of:

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.